Page last updated: 2024-09-03

glycyl-prolyl-arginyl-proline and glycyl-arginyl-glycyl-aspartyl-serine

glycyl-prolyl-arginyl-proline has been researched along with glycyl-arginyl-glycyl-aspartyl-serine in 1 studies

Compound Research Comparison

Studies
(glycyl-prolyl-arginyl-proline)
Trials
(glycyl-prolyl-arginyl-proline)
Recent Studies (post-2010)
(glycyl-prolyl-arginyl-proline)
Studies
(glycyl-arginyl-glycyl-aspartyl-serine)
Trials
(glycyl-arginyl-glycyl-aspartyl-serine)
Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-serine)
57010190042

Protein Interaction Comparison

ProteinTaxonomyglycyl-prolyl-arginyl-proline (IC50)glycyl-arginyl-glycyl-aspartyl-serine (IC50)
Integrin beta-3Homo sapiens (human)0.3343
Integrin alpha-V Homo sapiens (human)0.75
Integrin alpha-IIbHomo sapiens (human)0.1265

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adelman, B; Gennings, C; Hanners, E; Strony, J1

Other Studies

1 other study(ies) available for glycyl-prolyl-arginyl-proline and glycyl-arginyl-glycyl-aspartyl-serine

ArticleYear
Synergistic inhibition of platelet aggregation by fibrinogen-related peptides.
    Circulation research, 1990, Volume: 67, Issue:4

    Topics: Adenosine Diphosphate; Amino Acid Sequence; Drug Synergism; Fibrinogen; Humans; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors

1990